Targeting insulin inhibition as a metabolic therapy in advanced cancer: A pilot safety and feasibility dietary trial in 10 patients
Insulin inhibition effected by dietary CHO restriction was found safe and feasible in 10 patients with advanced cancer.
References:
Fine (2012). "Targeting insulin inhibition as a metabolic therapy in advanced cancer: A pilot safety and feasibility dietary trial in 10 patients." Nutrition 28: 1028-1035.